Amprenavir is a protease inhibitor used to treat HIV infection. It was approved by
the Food and Drug Administration on April 15, 1999, for twice-a-day dosing ...
Amprenavir is a Protease Inhibitor. The mechanism of action of amprenavir is as
a HIV Protease Inhibitor, and Cytochrome P450 3A4 Inhibitor, and Cytochrome ...
Amprenavir (Agenerase - discontinued brand) is a drug prescribed to treat
infections with HIV. Side effects, drug interactions, and pregnancy safety
information is ...
Apr 25, 2007 ... Amprenavir is an antiviral medication in a group of HIV medicines called
protease (PRO-tee-ayz) inhibitors. Amprenavir prevents human ...
Jul 16, 2008 ... Learn about the prescription medication Agenerase Capsules (Amprenavir
Capsules), drug uses, dosage, side effects, drug interactions, ...
(amprenavir). Capsules. PATIENT INFORMATION INCLUDED. Because of the
potential risk of toxicity from the large amount of the excipient, propylene glycol ...
Learn about indications, dosage and how it is supplied for the drug Agenerase
Capsules (Amprenavir Capsules).
AGENERASE (amprenavir) in combination with other antiretroviral agents is
indicated for ... contains 15 mg of amprenavir in solution and the inactive
Aug 2, 2002 ... (amprenavir). Capsules. PATIENT INFORMATION INCLUDED. Because of the
potential risk of toxicity from the large amount of the excipient ...
Agenerase (amprenavir): For the treatment of HIV-1 infection.. New approved
drug details including side effects, uses and general information.